AAVantgarde Closes €61 Million Series A Financing to Advance Two Therapeutic Programs into the Clinic
June 06, 2023 08:00 ET
|
AAVantgarde Bio
- Financing led by Atlas Venture and Forbion - Company created, incubated and seed financed by Sofinnova Partners MILAN, Italy, June 06, 2023 (GLOBE NEWSWIRE) -- AAVantgarde Bio (AAVantgarde), a...
Forbion announces first close of Forbion Growth Opportunities Fund II at €470 million
June 09, 2022 02:00 ET
|
Forbion
Forbion announces first close of Forbion Growth Opportunities Fund II at €470 million New fund to invest in late-stage European life sciences companiesInvestors include Pantheon, pension funds PME...
ARMGO Pharma raises $35 million to progress clinical studies of lead molecule ARM210 in cardiac and skeletal muscle diseases
December 20, 2021 07:00 ET
|
ARMGO
ARMGO Pharma raises $35 million to progress clinical studies of lead molecule ARM210 in cardiac and skeletal muscle diseases Series B investment led by Forbion and joined by Pontifax and Kurma...